Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rheumatoid neuropathy. Clinical and electrophysiological features.

Literature DB >> 4322141

Rheumatoid neuropathy. Clinical and electrophysiological features.

M A Chamberlain, F E Bruckner.

Abstract

Entities: Disease

Mesh：

Year: 1970 PMID： 4322141 PMCID： PMC1010591 DOI： 10.1136/ard.29.6.609

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

× No keyword cloud information.

10 in total

1. PERIPHERAL NEUROPATHY IN RHEUMATOID ARTHRITIS.

Authors: C A PALLIS; J T SCOTT
Journal: Br Med J Date: 1965-05-01

2. PERIPHERAL NEUROPATHY ASSOCIATED WITH RHEUMATOID ARTHRITIS. A CLINICAL AND ELECTRODIAGNOSTIC STUDY OF 70 CONSECUTIVE RHEUMATOID ARTHRITIS PATIENTS.

Authors: A E GOOD; R P CHRISTOPHER; G H KOEPKE; L F BENDER; M E TARTER
Journal: Ann Intern Med Date: 1965-07 Impact factor: 25.391

3. The range of conduction velocity in normal motor nerve fibers to the small muscles of the hand and foot.

Authors: P K THOMAS; T A SEARS; R W GILLIATT
Journal: J Neurol Neurosurg Psychiatry Date: 1959-08 Impact factor: 10.154

4. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors:
Journal: Ann Rheum Dis Date: 1959-03 Impact factor: 19.103

5. Rheumatoid neuropathy.

Authors: F D HART; J R GOLDING
Journal: Br Med J Date: 1960-05-28

6. The relationship of therapy with cortisone to the incidence of vascular lesions in rheumatoid arthritis.

Authors: J W KEMPER; A H BAGGENSTOSS; C H SLOCUMB
Journal: Ann Intern Med Date: 1957-05 Impact factor: 25.391

7. Sensory nerve action potentials in patients with peripheral nerve lesions.

Authors: R W GILLIATT; T A SEARS
Journal: J Neurol Neurosurg Psychiatry Date: 1958-05 Impact factor: 10.154

8. The relative excitability and conduction velocity of sensory and motor nerve fibres in man.

Authors: G D DAWSON
Journal: J Physiol Date: 1956-02-28 Impact factor: 5.182

9. Rheumatoid arthritis and polyarteritis nodosa.

Authors: J BALL
Journal: Ann Rheum Dis Date: 1954-12 Impact factor: 19.103

10. Rheumatoid neuropathy: a histological and electrophysiological study.

Authors: R O Weller; F E Bruckner; M A Chamberlain
Journal: J Neurol Neurosurg Psychiatry Date: 1970-10 Impact factor: 10.154

10 in total

12 in total

Rheumatoid neuropathy. Clinical and electrophysiological features.

1. PERIPHERAL NEUROPATHY IN RHEUMATOID ARTHRITIS.

2. PERIPHERAL NEUROPATHY ASSOCIATED WITH RHEUMATOID ARTHRITIS. A CLINICAL AND ELECTRODIAGNOSTIC STUDY OF 70 CONSECUTIVE RHEUMATOID ARTHRITIS PATIENTS.

3. The range of conduction velocity in normal motor nerve fibers to the small muscles of the hand and foot.

4. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

5. Rheumatoid neuropathy.

6. The relationship of therapy with cortisone to the incidence of vascular lesions in rheumatoid arthritis.

7. Sensory nerve action potentials in patients with peripheral nerve lesions.

8. The relative excitability and conduction velocity of sensory and motor nerve fibres in man.

9. Rheumatoid arthritis and polyarteritis nodosa.

10. Rheumatoid neuropathy: a histological and electrophysiological study.

Review 1. Beyond the joints: neurological involvement in rheumatoid arthritis.

2. Peripheral neuropathy and indomethacin.

Review 3. Peripheral neuropathy: clinical and electrophysiological considerations.

4. Intraarticular corticosteroid injection into rheumatoid arthritis knees improves extensor muscles strength.

5. Rheumatoid neuropathy.

6. Tryptophan metabolism in rheumatoid neuropathies.

7. Gold toxicity presenting as peripheral neuropathy.

8. Atrophy of the thumb web space in rheumatoid arthritis: clinical and electrodiagnostic studies.

Review 9. Peripheral neuropathies of the forearm and hand in rheumatoid arthritis: diagnosis and options for treatment.

10. The syndrome of continuous muscle fibre activity following gold therapy.